These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7976233)

  • 41. [Sodium valproate versus propranolol in the prophylactic treatment of migraine].
    Kozubski W; Prusiński A
    Neurol Neurochir Pol; 1995; 29(6):937-47. PubMed ID: 8714731
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Propranolol vs flunarizine vs flunarizine plus propranolol in migraine without aura prophylaxis. A double-blind trial.
    Bordini CA; Arruda MA; Ciciarelli MC; Speciali JG
    Arq Neuropsiquiatr; 1997 Sep; 55(3B):536-41. PubMed ID: 9629401
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The treatment of juvenile migraine using flunarizine or propranolol].
    Lütschg J; Vassella F
    Schweiz Med Wochenschr; 1990 Nov; 120(46):1731-6. PubMed ID: 2251492
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Tolfenamic acid versus paracetamol in migraine attacks. A double-blind study in general practice].
    Nørrelund N; Christiansen LV; Plantener S
    Ugeskr Laeger; 1989 Sep; 151(38):2436-8. PubMed ID: 2678652
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of comorbid migraine and temporomandibular disorders: a factorial, double-blind, randomized, placebo-controlled study.
    Goncalves DA; Camparis CM; Speciali JG; Castanharo SM; Ujikawa LT; Lipton RB; Bigal ME
    J Orofac Pain; 2013; 27(4):325-35. PubMed ID: 24171182
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy and safety of exogenous ketone bodies for preventive treatment of migraine: A study protocol for a single-centred, randomised, placebo-controlled, double-blind crossover trial.
    Gross E; Putananickal N; Orsini AL; Schmidt S; Vogt DR; Cichon S; Sandor P; Fischer D
    Trials; 2019 Jan; 20(1):61. PubMed ID: 30654835
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A double-blind randomized controlled trial of low doses of propranolol, nortriptyline, and the combination of propranolol and nortriptyline for the preventive treatment of migraine.
    Domingues RB; Silva AL; Domingues SA; Aquino CC; Kuster GW
    Arq Neuropsiquiatr; 2009 Dec; 67(4):973-7. PubMed ID: 20069203
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Propranolol and femoxetine, a HT-uptake inhibitor, in migraine prophylaxis. A double-blind crossover study.
    Andersson PG; Petersen EN
    Acta Neurol Scand; 1981 Oct; 64(4):280-8. PubMed ID: 7032183
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Safety and tolerability of short-term preventive frovatriptan: a combined analysis.
    MacGregor EA; Brandes JL; Silberstein S; Jeka S; Czapinski P; Shaw B; Pawsey S
    Headache; 2009 Oct; 49(9):1298-314. PubMed ID: 19788471
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A double blind controlled study of propranolol and cyproheptadine in migraine prophylaxis.
    Rao BS; Das DG; Taraknath VR; Sarma Y
    Neurol India; 2000 Sep; 48(3):223-6. PubMed ID: 11025624
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tolfenamic acid and mefenamic acid in the treatment of primary dysmenorrhoea.
    Delgado J; Simonin G; Servier C; García R; Yoma J
    Pharmacol Toxicol; 1994; 75 Suppl 2():89-91. PubMed ID: 7816793
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Migraine prophylactic drugs: proof of efficacy, utilization and cost.
    Ramadan NM; Schultz LL; Gilkey SJ
    Cephalalgia; 1997 Apr; 17(2):73-80. PubMed ID: 9137841
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Femoxetine - a new 5-HT uptake inhibitor - and propranolol in the prophylactic treatment of migraine.
    Kangasniemi PJ; Nyrke T; Lang AH; Petersen E
    Acta Neurol Scand; 1983 Oct; 68(4):262-7. PubMed ID: 6606930
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparing the Effects of Atorvastatin With Sodium Valproate (Divalproex) on Frequency and Intensity of Frequent Migraine Headaches: A Double-blind Randomized Controlled Study.
    Hesami O; Sistanizad M; Asadollahzade E; Johari MS; Beladi-Moghadam N; Mazhabdar-Ghashghai H
    Clin Neuropharmacol; 2018; 41(3):94-97. PubMed ID: 29746282
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomized controlled trial.
    Tronvik E; Stovner LJ; Helde G; Sand T; Bovim G
    JAMA; 2003 Jan; 289(1):65-9. PubMed ID: 12503978
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Propranolol and acetylsalicylic acid in migraine prophylaxis. Double-blind crossover study.
    Baldrati A; Cortelli P; Procaccianti G; Gamberini G; D'Alessandro R; Baruzzi A; Sacquegna T
    Acta Neurol Scand; 1983 Mar; 67(3):181-6. PubMed ID: 6868956
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A double-blind, randomized trial of low-dose topiramate vs propranolol in migraine prophylaxis.
    Ashtari F; Shaygannejad V; Akbari M
    Acta Neurol Scand; 2008 Nov; 118(5):301-5. PubMed ID: 18713156
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment of migraine with propranolol.
    Borgesen SE
    Postgrad Med J; 1976; 52 Suppl 4():163-5. PubMed ID: 787958
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis--a double-blind, multicentre, randomized placebo-controlled dose-response study.
    Pfaffenrath V; Diener HC; Fischer M; Friede M; Henneicke-von Zepelin HH;
    Cephalalgia; 2002 Sep; 22(7):523-32. PubMed ID: 12230594
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy and safety of cinnarizine in the prophylaxis of migraine headaches in children: an open, randomized comparative trial with propranolol.
    Togha M; Malamiri RA; Rashidi-Ranjbar N; Asa S; Mahvelati F; Ashrafi MR
    Acta Neurol Belg; 2012 Mar; 112(1):51-5. PubMed ID: 22427290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.